KBR

Bio Aprogen causes stir by reversing plan to acquire US plant Aprogen has reversed its plan to acquire a cGMP plant in the United States less than a day after the initial announcement, causing repercussions.“We are examining various strategie... Kim Chan-hyuk 2022-10-07 4:14 PM

Hospital Parkinson's DBS long-term study proves safe and effective, says SNUH researchers A recent long-term follow up study conducted by researchers at Seoul National University Hospital (SNUH) has shown that deep brain stimulation (DBS) of the subthalmic nucleus (STN)... Marianne Chang 2022-10-07 5:44 PM

Pharma Duchem Bio launches radiopharmaceutical for prostate cancer diagnosis in Korea Duchem Bio said it launched FACBC, the world’s first radiopharmaceutical used when diagnosing prostate cancer patients, in Korea.The drug, developed by Nihon Medi Physics, a Japane... Lee Han-soo 2022-10-07 5:14 PM

Pharma Qurient resumes trading on Kosdaq market The Korea Exchange (KRX) held a corporate review committee on Thursday and decided to maintain the listing of Qurient on the tech-heavy Kosdaq market. With the decision, Qurient's ... Lee Han-soo 2022-10-07 11:17 AM

Bio Severance Hospital researchers enhance tumor targeting 100 times with anticancer virus complex Severance Hospital said on Friday that its researchers have developed a mesenchymal stem cell (MSC)/anticancer virus complex carrier that improves the ability to quickly and accura... Marianne Chang 2022-10-07 3:20 PM

Hospital Essential care depts. will collapse in 2-3 decades due to few young doctors Essential medical departments are “growing old.” That’s because young doctors are not flowing in as they avoid choosing them as majors. Specialists in the essential but shunned dep... Song Soo-youn 2022-10-06 3:43 PM

Pharma SK Bioscience's Covid-19 vaccine barely used in Korea Almost no Korean is getting SK Bioscience's Covid-19 vaccine, SKYCovione, because the vaccine release was too late compared to foreign vaccines, government data showed.According to... Lee Han-soo 2022-10-06 1:49 PM

Bio Samsung Biologics jumps into bispecific antibodies CDMO biz Samsung Biologics is drawing the industry’s attention by preemptively launching a CDMO (contract development and manufacturing organization) business targeting the growing market o... Kim Chan-hyuk 2022-10-06 4:26 PM

Pharma Lotte Biologics victimized by a post from a fake BMS exec account Lotte Biologics recently had a bitter experience after a fake LinkedIn account posing as a key executive of Bristol-Myers Squibb (BMS) expressed “displeasure over the sale of the l... Lee Han-soo 2022-10-06 10:40 AM

Bio ‘Neoadjuvant TCHP reduces side effects of breast cancer drugs’ A team of researchers at Gangnam Severance Hospital said they discovered a pathological complete response (pCR) when administering HER2 positive breast cancer patients with a dose ... Marianne Chang 2022-10-06 11:39 AM

Pharma GC to co-market GSK's shingles vaccine GC and GSK Korea will jointly sell the latter's new shingles vaccine, Shingrix.According to industry sources, the two companies recently signed a co-promotion contract for Shingrix... Lee Han-soo 2022-10-06 3:11 PM

Policy Xocova’s expectations rise as nod seems near for antivirus Covid-19 drug A way has been opened to approve the first homegrown antiviral treatments for Covid-19.As the Ministry of Food and Drug Safety added "symptom improvement effect" to clinical evalua... Kim Chan-hyuk 2022-10-06 11:25 AM

Pharma Daewoong expands BTX market to UK with Nuceiva launch Daewoong Pharmaceutical said on Wednesday that it rolled out botulinum toxin "Nuceiva" (domestic product name: Nabota) in the U.K. last month through its partner, Evolus.The U.K. i... Marianne Chang 2022-10-06 12:56 PM

Device/ICT 'Value of NGS not yet fully recognized in Korea' Korea is utilizing only a fraction of the potential of next generation sequencing (NGS) and has yet to recognize the full value of the platform, Illumina's sales head for the Asia ... Lee Han-soo 2022-10-05 3:33 PM

Device/ICT Shares of diagnostic kit makers plummet as pandemic slows down In-vitro diagnostic medical device companies, whose stock prices soared amid expectations for growth during the COVID-19 pandemic, are struggling to escape from a recent slump.Top ... Lee Han-soo 2022-10-05 4:31 PM

Bio Celltrion’s 4-month performance in digital care graded ‘poor’ Celltrion’s ambitious intestinal disease management app, named “Manager Care,” has been confirmed to suffer from sluggish download numbers four months after its launch, according t... Kim Chan-hyuk 2022-10-05 4:57 PM

Device/ICT Plasmapp to expand into new bioindustries with IPO on Kosdaq Plasmapp, a bio plasma technology company, said it would expand its research and development (R&D) platform to accelerate the development of its pipeline biomedical devices by goin... Marianne Chang 2022-10-05 4:27 PM

Policy Regulator failed to inspect 2 clinics prescribing ‘too many narcotic diet pills’ The Ministry of Food and Drug Safety (MFDS) has failed to inspect two clinics that prescribed 342 times the average prescription of narcotic appetite suppressants by all doctors, a... Kim Yoon-mi 2022-10-05 2:39 PM

Pharma US clinical trial of Icure’s dementia patch delayed to next year The U.S. clinical trial of Icure Pharmaceutical’s donepezil-containing patch-type (percutaneous absorption drug) dementia treatment will be postponed to 2023.On Tuesday, Icure unve... Kim Chan-hyuk 2022-10-05 11:20 AM

Hospital Pros and cons of telemedicine clash in ethics panel debate A debate took place on Tuesday whether the “advantage” of non-face-to-face treatment that patients receive treatment whenever and wherever they want could be accepted from the aspe... Koh Jung Min 2022-10-05 4:19 PM

Pharma Korea Pharma, G2GBIO, Humedix ink deal for donepezil injection-based Alzheimer’s... Korea Pharma said Wednesday that it signed a joint development contract with G2GBIO and Humedix to develop a one-month long-lasting Alzheimer's dementia injection-based treatment c... Marianne Chang 2022-10-05 10:14 AM

Policy ECCK demands Korea’s deregulation for better patient access to innovative medicines The EU Chamber of Commerce in Korea (ECCK) recently requested the Korean government to improve drug-related regulations in the ECCK White Paper 2022, published on Friday.The white ... Lee Han-soo 2022-10-05 10:14 AM

Hospital How could Inha University Hospital become No. 1 in patient experience evaluation? A medical institution received outstanding results in all three patient experience evaluations. It’s Inha University Hospital.Inha University Hospital’s grades went up as the evalu... Song Soo-youn 2022-10-04 1:51 PM

Special Mongolian doctors give Kangbuk Samsung Hospital’s automated lab 5-star review Kangbuk Samsung Hospital has been running the Mongolia National Diagnostic Treatment Center (NDTC) Operation Management Consulting Project since July 2020 to provide training for M... Marianne Chang 2022-10-04 5:28 PM

Policy Proposal to set up narcotics agency raises concern over dispersing control tower After the so-called Three Drug Acts, which calls for establishing the narcotics agency, was proposed, concerns are growing that the administrative power of the existing department ... Kim Chan-hyuk 2022-10-04 4:53 PM

Hospital 'Automatic brain volume measurement enables early diagnosis of Alzheimer's disease' Researchers at St. Mary's Hospital have developed Quick Brain Volumetry (QbraVo), an automatic imaging program that can analyze brain volume using MRI, and a new imaging index that... Lee Han-soo 2022-10-04 11:43 AM

Hospital Doctors’ emotional labor grows in proportion to their interactions with patients A recent study showed that the more interactions physicians have with patients, the greater their emotional labor.Kim Jin-sook, a researcher at the Medical Policy Research Institut... Kim Ju-yeon 2022-10-04 4:14 PM

Bio What are the obstacles to developing microbiome therapeutics? Korean companies are rapidly joining the race to develop microbiome-based live biotherapeutic products (LBPs).Industry officials and academics recently gathered in Seoul to discuss... Kim Chan-hyuk 2022-10-04 2:27 PM

Pharma Yuyu presents dry eye treatment candidate at US ophthalmology meet Yuyu Pharmaceutical CEO Robert Yu promoted YP-P10, a dry eye syndrome treatment candidate, during the 2022 American Academy of Ophthalmology (AAO) Conference held in Chicago, U.S.,... Lee Han-soo 2022-10-04 10:24 AM

Device/ICT Panagene wins permit for TERT genetic test kit Panagene, a domestic molecular diagnostics company, said on Tuesday that it obtainedapproval from the Ministry of Food and Drug Administration (MFDS) for its PNA Clamp TERT Mutatio... Marianne Chang 2022-10-04 1:58 PM

Policy Narcotics becoming more popular among young Koreans as prices drop From famous music producers to young adults traveling from abroad, an increasing number of Koreans are using narcotics. Don Spike, a music producer, was arrested on Monday for usin... Lee Han-soo 2022-09-30 5:23 PM

Special Expert shares how vaccine modelling can save lives Dr. Elizabeth Lee of Epidemiology at Johns Hopkins University expressed her passion for the impact of vaccines that could save people’s lives after giving a lecture on using real-w... Marianne Chang 2022-09-30 4:15 PM

Pharma Korean pharma immersed in AI drug development An artificial intelligence (AI)-based new drug development boom has erupted among Korean pharmaceutical companies.According to industry insiders, AI platform makes the new drug d... Lee Han-soo 2022-09-30 4:17 PM

Hospital 'AI for Children' hoped to advance diagnosing, treating rare diseases in children Artificial intelligence (AI) integrated solutions that can be used through the entire cycle of diagnosing, treating, and managing prognosis for children with rare diseases will be ... Kim Eun-young 2022-09-30 2:40 PM

Policy DPK lawmaker calls for ‘treatment guideline’ for 54,000 long-Covid patients A lawmaker on Friday called for preparing a Korean version of a treatment guideline for people suffering from Covid-19’s aftereffects, saying their number exceeded 54,000 in the pa... Kwak Sung-sun 2022-09-30 3:42 PM

Device/ICT How to rate insurance fees for digital healthcare service “Patient-centeredness" is essential to develop digital healthcare, an expert pointed out Thursday. Moving away from the existing evaluation of commercial viability, it is necessary... Kim Eun-young 2022-09-30 3:09 PM

Pharma Police probes Ilyang Pharma for 'exaggerating Covid-19 treatment study results' to inflate stock price The police have begun investigating Ilyang Pharmaceutical on charges of exaggerating the results of a study on Covid-19 treatment candidate to inflate its stock price, local news r... Lee Han-soo 2022-09-30 2:35 PM

Device/ICT NGeneBio develops blood-based dementia diagnostic device NGeneBio said on Friday it has developed a prototype of a blood-based in vitro diagnostic device to detect early dementia using a biomarker discovered in the National Dementia Rese... Marianne Chang 2022-09-30 10:29 AM

Hospital 'Pandemic worsened memory, recall function among elderly without Covid-19 infection' The cognitive function such as memory and recall abilities among the Korean elderly declined much more during the Covid-19 pandemic than before the pandemic, even though they did n... Kim Ju-yeon 2022-09-30 3:14 PM

Hospital How could Myongji Hospital comfort staff exhausted by Covid-19? As Covid-19 has continued for years, many domestic medical institutions are dedicating themselves to responding to the pandemic. Myongji Hospital is also one of the institutions th... Kwak Sung-sun 2022-09-29 1:27 PM

Pharma 'Open innovation takes up over half of multinational drugmakers' R&D budget' "Global pharmaceutical companies are constantly finding new ways to develop innovative drugs despite the recent Covid-19 pandemic."Yoshitake Maeda, the director of Bristol Myers Sq... Lee Han-soo 2022-09-29 2:26 PM

Pharma Daewoong, AZothBio to co-research AI-based new cancer drugs Daewoong Pharmaceutical said Wednesday that the company signed a contract with AZothBio to research and develop synthetic lethality anticancer treatments using artificial intellige... Kim Chan-hyuk 2022-09-29 3:07 PM

Bio GC Genome releases ‘Hair Loss Risk Screen’ test GC Genome said Thursday that it has launched the “Hair Loss Risk Screen” test, which can check the risk of genetic development by hair loss type by selecting genes related to hair ... Kim Chan-hyuk 2022-09-29 3:32 PM

Policy Bioclusters should identify core competence, expert says The biotech industry has recently become a key sector for many countries as the industry supports the health of citizens in an aging society and serves as an engine for economic gr... Lee Han-soo 2022-09-29 4:14 PM

Hospital 'Genetic mutation called CHIP related to severe Covid-19 in patients without underlying diseases' A joint team of Korean researchers discovered that clonal hematopoiesis of indeterminate potential (CHIP), a genetic mutation, was the risk factor for severe Covid-19 patients with... Lee Han-soo 2022-09-29 1:00 PM

Bio TiumBio gets $4.5 million upfront from China’s Hansoh Pharmaceutical TiumBio said on Tuesday that it received a $4.5 million upfront payment from China’s Hansoh Pharmaceutical under the previous licensing agreement involving TU2670, a new endometrio... Kim Chan-hyuk 2022-09-29 10:43 AM

Policy Opposition lawmaker raises question about KODC’s raison d’etre The Korea Orphan and Essential Drug Center (KODC) established to supply essential drugs safely, is not playing its role, an opposition lawmaker pointed out, criticizing it for not ... Kim Eun-young 2022-09-29 4:46 PM

Pharma Celltrion's Avastin biosimilar wins domestic permit, after scoring nod in US, Europe Celltrion said Wednesday that it obtained a domestic license from the Ministry of Food and Drug Safety (MFDS) for its Avastin biosimilar, Vegzelma (ingredient name: bevacizumab).Co... Marianne Chang 2022-09-29 11:35 AM

Device/ICT VUNO Med-Fundus AI gets OK from Singapore’s regulator Vuno, a company specialising in global medical artificial intelligence (AI) solutions, said on Thursday that its AI-based fundus reading solution VUNO Med-Fundus AI has obtained me... Marianne Chang 2022-09-29 1:32 PM

Bio Samsung Bioepis to disclose data of Eylea biosimilar for 1st time at US ophthalmology meet Samsung Bioepis said Tuesday that it would present three scientific abstracts for its ophthalmology biosimilars at the American Academy of Ophthalmology (AAO) 2022 from Sept. 30 to... Marianne Chang 2022-09-28 1:07 PM

상단영역

본문영역